Brief: Virios Therapeutics Announces Pricing Of $1.7 Million Public Offering Of Common Stock
20/05/2024 01:54
May 19 (Reuters) - Virios Therapeutics Inc VIRI.O :
* VIRIOS THERAPEUTICS ANNOUNCES PRICING OF $1.7 MILLION
PUBLIC
OFFERING OF COMMON STOCK TO COMMENCE PREPARATIONS FOR PLANNED
IMC-2 LONG-COVID PHASE 2B STUDY
* PRICING OF OFFERING OF 8.5 MILLION SHARES OF ITS COMMON
STOCK AT
A PRICE OF $0.20 PER SHARE
Source text for Eikon: ID:nGNX6dJwVp
Further company coverage: VIRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study